menu
    • menu

    Company profile for Invivyd

    NEW Drugs in Dev: 6
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Invivyd is developing antibodies to transcend the limits of naturally occurring immunity and provide higher levels of protection from viral diseases, beginning with COVID-19. We are driven to change the paradigm for combatting viral infection by delivering rapid and lasting antibody immunity to protect the general public and ensure vulnerable populations are never left behind.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    InvivydUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1601 Trapelo Rd. Suite 178 Waltham, MA 02451
    Telephone
    Telephone
    781-819-0080
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://invivyd.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/invivyd/?viewAsMember=true
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/invivyd

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Invivyd Advances Novel Potential 1st-in-Class mAb Candidate
    Invivyd Advances Novel Potential 1st-in-Class mAb Candidate

    09 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/09/3270803/0/en/Invivyd-Announces-REVOLUTION-Program-Progress-and-Advancement-of-Novel-Potential-First-and-Best-in-Class-Measles-Monoclonal-Antibody-Candidate-VMS063-for-Treatment-and-Prevention-o.html

    GLOBENEWSWIRE
    09 Apr 2026
    Share Share
    Invivyd Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)
    Invivyd Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)

    06 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/06/3268347/0/en/Invivyd-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    06 Apr 2026
    Share Share
    Invivyd Presents At World Vaccine Congress Washington
    Invivyd Presents At World Vaccine Congress Washington

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3265002/0/en/Invivyd-Announces-Presentation-at-the-World-Vaccine-Congress-Washington.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Invivyd Reports Q4 and FY 2025 Results, Declaration Updates
    Invivyd Reports Q4 and FY 2025 Results, Declaration Updates

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3250025/0/en/Invivyd-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Recent-Business-Highlights-and-DECLARATION-Clinical-Trial-Updates.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share
    Invivyd Names Michael Mina, M.D., Ph.D. Chief Medical Officer
    Invivyd Names Michael Mina, M.D., Ph.D. Chief Medical Officer

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3250023/0/en/Invivyd-Appoints-Distinguished-Physician-and-Scientist-Michael-Mina-M-D-Ph-D-as-Chief-Medical-Officer.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share
    Invivyd Hosts Q4, FY 2025 Results Call March 5, 2026
    Invivyd Hosts Q4, FY 2025 Results Call March 5, 2026

    02 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/02/3247875/0/en/Invivyd-to-Host-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Corporate-Update-Conference-Call-on-March-5-2026.html

    GLOBENEWSWIRE
    02 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search